Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The YOGICO study aims to characterize the distinctive features of EoGI cancer through a holistic approach that integrates clinical and demographic data, tumor biological characteristics, and patient lifestyle habits
This is an observational, prospective multicenter study to characterize newly diagnosed EoGI cancer patients from a holistic approach, covering aspects from tumor features to patient lifestyle habits. Since this is a prospective observational study, participation does not alter any cancer treatments that patients will undergo after their cancer diagnosis, as per best clinical practice at each participating center. The number of patients included in the study will range from 150 to 200, enrolled in national centers located in northern Italy, as well as in diverse hospital settings (e.g., small vs. large hospitals).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| EoGI cancer patients newly diagnosed |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| to characterize the distinctive features of EO-GI cancer through a comprehensive approach that considers clinical and demographic factors, tumor features, and patient lifestyle habits | Other | to characterize the distinctive features of EO-GI cancer through a comprehensive approach that considers clinical and demographic factors, tumor features, and patient lifestyle habits, in a real-world Italian settings, mainly located in Northern Italy |
| Measure | Description | Time Frame |
|---|---|---|
| Primary outcome | Describe clinical and tumor features of newly diagnosed EoGI cancer patients in a real-world Italian setting. | One year from the enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Secondary outcome measure | EoGI cancer type of treatment at diagnosis (chemotherapy, immunotherapy, targeted therapy, surgery, radiotherapy or best supportive care); progression of disease (if any) and survival status at 6 and 12 months follow-up. | Six and twelve months follow-up |
| Secondary Outcome |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients will be selected and recruited during routine medical appointments by specialized medical oncologists at the participating cancer center. Patients will be enrolled consecutively based on inclusion and exclusion criteria
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ilaria Bernardini, MD | Contact | +39 059659294 | i.bernardini@ausl.mo.it |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Oncologia, Ospedale Sant'Orsola | Bologna | BO | Italy |
Not provided
Not provided
Not provided
Not provided
|
Incidence and prevalence of newly diagnosed EoGI cancer at each participating site during the study accrual time period |
| Two years |
| Secondary Outcome | Description of patients' lifetime exposure to behavioral and cancer-related risk factors | One years from enrollment |
| Secondary Outcome | Identify associations between past lifestyle habits (diet, physical activity, smoking, alcohol consumption,) and tumor-related features (stage, histology, anatomical site, and molecular markers) in EoGI cancer patients | One years from enrollment |
| Istituto Romagnolo per lo studio dei tumori "Dino Amadori", IRCCS IRST | Meldola | FC | Italy |
|
| Oncologia Ospedale Carlo Poma di Mantova | Mantua | MN | Italy |
|
| Oncologia di Prossimità, Ospedale di Carpi e DHO Mirandola, Ausl Modena | Carpi | MO | Italy |
|
| Centro Oncologico Modenese, Azienda Policlinico Universitaria di Modena | Modena | MO | Italy |
|
| Oncologia Area Sud Ausl Modena | Sassuolo | MO | Italy |
|
| Oncologia Medica, AUSL Piacenza | Piacenza | PC | Italy |
|
| Oncologia, Azienda Ospedaliero Universitaria di Parma | Parma | PR | Italy |
|
| Oncologia Medica, CORE Azienda USL-IRCCS Reggio Emilia | Reggio Emilia | RE | Italy |
|
| Oncologia, Ospedale di Rimini | Rimini | RN | Italy |
|
| Oncologia, ASST SETTE LAGHI, Ospedale di Circolo | Varese | VA | Italy |
|
| ID | Term |
|---|---|
| D003710 | Demography |
| ID | Term |
|---|---|
| D011154 | Population Characteristics |
| D015991 | Epidemiologic Measurements |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
Not provided
Not provided